嘗高美集團(08371.HK)盈喜:預期上半財年集團將錄得大幅增長
格隆匯11月7日丨嘗高美集團(08371.HK)公佈,根據對集團截至2023年9月30日止六個月未經審核綜合管理賬的初步審閲,預期集團將錄得大幅增長,收入較截至2022年9月30日止六個月增長超過45%。
增加原因主要受惠於:(1)該期間開設的更多餐廳以及去年開業的餐廳在該期間貢獻了完整六個月的營業額;(2)人均消費增加;及(3)於同期期間,在2022年1月上旬至2022年4月下旬執行下午6點後禁止堂食。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.